Mona Mashayekhi
Vanderbilt University Medical Center
4 papersORCID 0000-0003-0331-2395OpenAlex
Vanderbilt University Medical Center
Is this you? Claim this profile
Papers
ENDO 2025 Abstract
SUN-559 Empagliflozin Reduces Monocyte-Platelet Aggregates: A Link to Cardiometabolic Benefits
Non-randomized trial in 8 peopleEmpagliflozin
Trends in Endocrinology and Metabolism
Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors
ReviewSGLT2 inhibitors
Diabetes, Obesity & Metabolism
Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes
Randomized trial in 88 peopleDietary restriction
Works at
Vanderbilt University Medical Center
Assistant professor
Sources: reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
K23, The Effect of SGLT2 Inhibition on Adipose Tissue Inflammation and Endothelial Function, K23HL159351, 2023–2028, Jun 30, 2026
Sources: reporter.nih.gov